PEDIATRICS Vol. 63 No. 1 January 1979, pp. 73-79
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papageorgiou, A. N.
Right arrow Articles by Gelfand, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papageorgiou, A. N.
Right arrow Articles by Gelfand, M. M.

The Antenatal Use of Betamethasone in the Prevention of Respiratory Distress Syndrome: A Controlled Double-Blind Study

Apostolos N. Papageorgiou M.D., F.R.C.P.(C)1, Marie F. Desgranges M.D., F.R.C.P.(C)1, Michel Masson M.D.1, Eleanor Colle M.D.1, Richard Shatz M.D., F.R.C.S.(C)1, and Morrie M. Gelfand M.D., F.R.C.S.(C)1

1 Departments of Pediatrics and Obstetrics and Gynecology, McGill University, The Jewish General Hospital Perinatal Unit, and The Montreal Children's Hospital-McGill University Research Institute, Montreal

One hundred forty-six pregnant women were enrolled in a prospective double-blind study to assess the effectiveness and side-effects of antenatal administration of betamethasone in the prevention of respiratory distress syndrome (RDS) in potentially premature infants. On admission to the study, the women were given, at random, either 12 mg of betamethasone or placebo. The same dose was repeated 24 hours later and then weekly up to 34 weeks of gestation. Gestational age of the infants ranged from 25 to 34 weeks, and birth weights ranged between 730 and 2,650 gm. Statistically significant differences in favor of the infants in the betamethasone group were found in the incidence of RDS, 20.7 in the betamethasone group compared with 59.5% in the control group (P < .005); in the severity of RDS (P < .05); and in the death rate (P < .05). A higher incidence of hypoglycemia was found among infants in the betamethasone group (P < .05). Prolonged rupture of the membranes played no protective role against RDS, and the incidence of infection was similar in both groups.

Submitted on July 25, 1978
Accepted on October 9, 1978




This article has been cited by other articles:


Home page
 PediatricsHome page
W. A. Engle and and the Committee on Fetus and Newborn
Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Pediatrics, February 1, 2008; 121(2): 419 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
M. B. Bracken, E. W. Triche, K. Belanger, A. Saftlas, W. S. Beckett, and B. P. Leaderer
Asthma Symptoms, Severity, and Drug Therapy: A Prospective Study of Effects on 2205 Pregnancies
Obstet. Gynecol., October 1, 2003; 102(4): 739 - 752.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. E. Lawson
Antenatal Corticosteroids--Too Much of a Good Thing?
JAMA, October 3, 2001; 286(13): 1628 - 1630.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. Walfisch, M. Hallak, and M. Mazor
Multiple Courses of Antenatal Steroids: Risks and Benefits
Obstet. Gynecol., September 1, 2001; 98(3): 491 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. ELIMIAN, U. VERMA, J. CANTERINO, J. SHAH, P. VISINTAINER, and N. TEJANI
Effectiveness of Antenatal Steroids in Obstetric Subgroups
Obstet. Gynecol., February 1, 1999; 93(2): 174 - 179.
[Abstract] [Full Text] [PDF]